SREBF1 and Obesity: Kim et al. (2013), for example, reported that LGG improved insulin sensitivity and reduced adiposity in a DIO mice model, together with a significant reduction of SREBP1c in mesenteric adipose tissue as a key biomarker of anti-obesity effects.